Virtual Pharma Partners: Guiding Assets to Commercialization

Seeking Strategic Investments

There are many investment models used in the therapeutics sector, including partnering with an innovative, hands-on, asset-centric Virtual Pharma group. These investors, otherwise known as pharmaceutical management companies or pharmaceutical development companies, partner with small biotechs with the goal of building a portfolio of therapeutic assets and efficiently developing them for an exit opportunity. But how do virtual pharmas operate, and why might it make sense to partner with one?

The research team at LSN keeps in contact with virtual pharma groups because, quite simply, they are investors in early stage biotech. Rather than investing directly in companies, virtual pharmas invest in assets (in most cases, by in-licensing and then funding the asset's development; in a few cases, by acquiring assets completely, often with the original rights owner maintaining a royalty share)...